New England Research & Management, Inc. Ionis Pharmaceuticals Inc Transaction History

New England Research & Management, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Oct 08, 2020	SELL	$47.45 - $62.95 $896,330 - $1.19 Million	-18,890 Closed	0 $0
Q2 2020 Jul 15, 2020	SELL	$46.85 - $61.05 $53,877 - $70,207	-1,150 Reduced 5.74%	18,890 $1.11 Million
Q1 2020 Jun 15, 2020	BUY	$41.6 - $63.4 $436,384 - $665,066	10,490 Added 109.84%	20,040 $947,000
Q4 2019 Jan 14, 2020	BUY	$53.85 - $65.27 $514,267 - $623,328	9,550 New	9,550 $577,000

402

136M

862K

582K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.1B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of New England Research & Management, Inc., based on Form 13F filings with the SEC.

Stay updated on New England Research & Management, Inc. with notifications on news.